Anti-tumor activity of PEGylated human IL-10 (AM0010) in patients with pancreatic or colorectal cancer.
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Kyriakos P. Papadopoulos, Aung Naing, Jeffrey R. Infante, Karen A. Autio, Patrick Alexander Ott, Deborah Jean Lee Wong, Gerald Steven Falchook, Manish R. Patel, Shubham Pant, Melinda Whiteside, John B Mumm, Ivan H Chan, Johanna C. Bendell, Drew W. Rasco, Kent C. Shih, Milind M. Javle, Todd Michael Bauer, Rivka R Colen, Peter Van Vlasselaer, Martin Oft
Institutions: South Texas Accelerated Research Therapeutics, The University of Texas MD Anderson Cancer Center, Sarah Cannon, Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, University of California, Los Angeles, Ronald Reagan UCLA Medical Center, University of Oklahoma Health Sciences Center, Tennessee Oncology
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2730763593